|
|
||||||||
Divisions of 1Molecular Pharmacology and 2Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan
Submitted 21 November 2005 ; accepted in final form 30 August 2006
| ABSTRACT |
|---|
|
|
|---|
-phorbol-12,13-didecanoate (4
PDD), an agonist of TRPV4. No flow dependence of net K+ and Na+ transports or effects of 4
PDD on CCDs were observed in TRPV4/ mice. A basolateral application of 4
PDD had little effect on these ion transports in the TRPV4+/+ CCDs, while the luminal application did. Urinary K+ excretion was significantly smaller in TRPV4/ than in TRPV4+/+ mice when urine production was stimulated by a venous application of furosemide. These observations suggested an essential role of the TRPV4 channels in the luminal or basolateral membrane as flow sensors in the mechanism underlying the flow-dependent K+ secretion in mouse CCDs. shear stress; mechanoreceptor; K+ excretion; maxi-K+ channel
Urinary excretion of K+ depends on urine volume, which was explained by flow-dependent K+ secretion from distal nephron segments, including the distal convoluted tubule, connecting tubule (CNT), and cortical collecting duct (CCD) (8). Taniguchi and Imai (20) found, using patch-clamp and in vitro microperfusion techniques, that the Ca2+-activated maxi-K+ channel in the luminal membrane of rabbit CNTs was apparently stretch activated in the presence of extracellular Ca2+; in addition, they demonstrated that the increase in luminal flow augmented the K+ conductance in the luminal membrane, which was completely inhibited by charybdotoxin (CTX), a selective blocker of maxi-K+ channels (10, 18, 20). Similar stretch activation of maxi-K+ channels was reported in the apical membrane of A3 cells derived from a rabbit medullary thick ascending limb (19). In addition, the parathyroid hormone (PTH)-dependent luminal Ca2+ influx was flow dependently increased via stretch-activated Ca2+-permeable cation channels in the luminal membrane of rabbit CNTs (21). It is possible that K+ ions were secreted via maxi-K+ channels that were activated by luminal Ca2+ influx via stretch-activated Ca2+-permeable cation channels, because the maxi-K+ channels themselves are not stretch activated in rabbit CNTs (20) and A3 cells (19). This hypothesis was supported by observations using an in vitro microperfusion technique showing that net K+ secretion in the rabbit CCDs consisted of flow-dependent and flow-independent components and that CTX blocked the flow-dependent component (27). The requirement of the Ca2+ influx, however, has been controversial in flow-dependent K+ secretion via maxi-K+ channels, because maxi-K+ channels are stretch activated Ca2+ independently in rat CCDs (13). Recently, it was reported that an in vivo kaliuretic response to volume expansion was lost in knockout mice through gene disruption of the maxi-K+ channel
1-subunit, which enhances the Ca2+ sensitivity of this channel (14). This result suggests that the essential role of a Ca2+ mobilization modulator, such as the stretch-activated cation channel, is to sense luminal flow. Although the mechanism has been described in detail for flow-dependent K+ secretion, no mechanosensitive molecular information has been available until now.
Abundant expression of TRPV4 channels has been detected in the kidney (7), but details regarding their localization are not available. Tian et al. (22) detected basolateral expression of TRPV4 using a sensitive antibody in all nephron segments after the ascending thin limb, except the macula densa, in rat and mouse kidneys. However, protein kinase C and casein kinase substrate in neurons (PACSIN3) were recently reported to be binding proteins of TRPV4 and to colocalize in the luminal membrane of renal tubules (3). Thus the precise localization of TRPV4 is controversial and may depend on the antibody used.
In this study, we compared net K+ flux in CCDs isolated from either TRPV4+/+ or TRPV4/ mice with an in vitro microperfusion technique to explore the role of TRPV4 channels as a flow sensor in the mechanism underlying flow-dependent K+ secretion. We also investigated urinary K+ excretion in vivo in both types of mice, in which urine production had been accelerated by furosemide.
| METHODS |
|---|
|
|
|---|
In vitro microperfusion. In preliminary experiments, we could not detect the net fluxes of Na+ and K+ in CCDs isolated from normal TRPV4+/+ and TRPV4/ mice with an in vitro microperfusion technique. Similar results were reported in rat CCDs, but the net fluxes of Na+ and K+ were augmented in CCDs isolated from rats pretreated with mineral corticoids (24). Thus we pretreated both male TRPV4+/+ and TRPV4/ mice with 2 mg·mouse1·day1 deoxycorticosterone acetate (DOCA; Sigma, St. Louis, MO) subcutaneously (sc) for 6 days for accurate measurements of K+ and Na+ fluxes in mouse CCDs with the in vitro microperfusion technique.
Either a TRPV4+/+ or a TRPV4/ mouse was anesthetized intraperitoneally (ip) with 40 mg/kg body wt (BW) pentobarbital sodium (Nembutal, Abbott, IL, or Somnopentyl, Sankyo, Tokyo, Japan), and its kidney was excised. We isolated CCDs from thin slices of renal cortex in chilled modified Collins' solution (4°C) that contained (in mM) 14 KH2PO4, 14 K2HPO4, 15 KCl, 9 NaHCO3, and 160 sucrose (pH 7.4). The CCDs were transferred to a bathing chamber mounted on an inverted microscope (IMT-2; Olympus, Tokyo, Japan). Single isolated CCDs were then perfused according to the technique reported by Burg et al. (2) with slight modifications (25). The net fluxes of water (Jv), K+ (JK), and Na+ (JNa) were measured at room temperature, when the tubular lumen was perfused at a perfusion pressure of 0.7 kPa applied to the inner perfusion pipette for the slower luminal flow (23 nl/min) or 1.2 kPa for the faster luminal flow (89 nl/min). The composition of the bathing and luminal solutions consisted of (in mM) 110 NaCl, 5 KCl, 25 NaHCO3, 0.8 Na2HPO4, 0.2 NaH2PO4, 10 Na-acetate, 1.8 CaCl2, 1.0 MgCl2, 8.3 glucose, and 5 alanine. The osmolality of this solution was 285295 mosmol/kgH2O, and the solution was equilibrated with 95% O2-5% CO2 (pH 7.4).
We obtained the net water flux across the perfused CCDs by measuring the inulin concentration in the perfusate and tubular effluent with the following equation
![]() | (1) |
![]() | (2) |
Measurement of urinary K+ excretion in vivo. Both types of male mice were anesthetized ip with 40 mg/kg BW pentobarbital sodium, and they were laid on a warmed bed (3840°C). We opened the lower abdomen to insert glass tubing into the urinary bladder. To increase urine production, we continuously infused 2% NaCl solution from the tail vein at a rate of 20 ml·h1·kg BW1 throughout the experiment. After the infusion of this solution for 1 h, urine was collected from the glass tubing into a polyethylene tube with a vacuum pump for 30 min as control urine. We then collected another urine sample for 10 min after urine production was further accelerated by iv application of 2 mg/kg BW furosemide. This urine collection was begun at 5 min after the application of furosemide. We also collected urine samples from both types of mice pretreated with DOCA, as described above, using the same protocol.
We measured the urine volume with a micropipette. The entire urine sample was carefully sucked into the plastic tip of a micropipette. It was then pushed forward by turning the volumetric screw until the urine reached the tip. A reading of the scale showed the urine volume. The urinary K+ concentration was measured with the flame-photometer IL 943 (Instrumentation Laboratory, Milan, Italy), and the urinary excretion of K+ was obtained from the urine volume and K+ concentration.
Reagents.
CTX (Peptide Institute, Osaka, Japan) was dissolved in purified water at 100 µM, and the solution was stocked at 20°C. The stock solution of CTX was diluted at 1 µM in the luminal perfusate. Amiloride (Sigma) was also dissolved at 10 µM in the luminal perfusate. DOCA (Sigma) was suspended at 20 mg/ml in olive oil. Furosemide (Sigma) was dissolved at 0.4 mg/ml in 0.9% NaCl containing 0.01 N NaOH. We dissolved 4
-phorbol-12,13-didecanoate (4
PDD; Sigma) at 10 mM in dimethylsulfoxide and added it to a luminal perfusate or bathing solution at a final concentration of 50 µM. The final concentration of dimethylsulfoxide was 0.2%. Sodium green (Molecular Probe) was dissolved at 64 µM in a 10 mM TRIZMA HCl/base buffer adjusted at pH 7.5. FITC-inulin (Sigma) was added into the luminal perfusate at 10100 µM. All solutions and suspensions, except for the stock solution, were prepared before use.
Statistics. Data are given as the means ± SE (n = no. of experiments). Statistical significance in the mean values was evaluated by either Student's t-test or Tukey-Kramer's multiple comparison test. P values < 0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
Both K+ secretion and Na+ reabsorption at faster luminal flow rate showed a significant increase of more than threefold compared with those at a slower luminal flow rate in the CCDs isolated from TRPV4+/+ mice (TRPV4+/+ CCDs) (Fig. 1). In contrast to this, no significant augmentation of K+ secretion and Na+ reabsorption was found in the CCDs isolated from TRPV4/ mice (TRPV4/ CCDs) as a result of an increase in the luminal flow rate. The flow-dependent transport of either K+ or Na+ was completely lost in the CCDs by disruption of the TRPV4 gene.
|
PDD on ion transports in CCDs.
It is known that 4
PDD activates the TRPV4 channel (5, 26). Thus we examined the effects of 4
PDD on both K+ secretion and Na+ reabsorption in isolated CCDs. In a preliminary experiment (see Supplemental Fig. S1; the online version of this article contains supplemental data), 4
PDD dose dependently induced a rise in [Ca2+]i in cortical renal tubule suspensions obtained from TRPV4+/+ but not in those obtained from TRPV4/. The [Ca2+]i was almost fully increased at 50 µM 4
PDD. Therefore, we employed this dosage for the full activation of TRPV4. As shown in Fig. 2A, a luminal application of 50 µM 4
PDD significantly stimulated the K+ secretion in TRPV4+/+ CCDs at a faster luminal flow rate. However, K+ secretion was not completely stimulated by 4
PDD at a faster flow rate in TRPV4/ CCDs (Fig. 2B). No significant stimulation of K+ secretion by luminal 4
PDD was observed at a slower luminal flow rate in either TRPV4+/+ CCDs (Fig. 2A) or TRPV4/ CCDs (Fig. 2B). Similar results were obtained in Na+ reabsorption, which was simultaneously measured with K+ secretion (Fig. 3). It should be noted that 4
PDD did not stimulate K+ and Na+ transports in the absence of the TRPV4 channel, even though this phorbol ester might not be specific to the TRPV4 channel.
|
|
PDD was applied at the same concentration from the basolateral side on TRPV4+/+ CCDs (Fig. 4). A basolateral application of 4
PDD caused a statistically significant but much smaller increase in the K+ secretion in TRPV4+/+ CCDs than that caused by its luminal application. Thus the effects of basolateral 4
PDD on these ion transports were clearly different from those of luminal application.
|
PDD in TRPV4+/+ but not in TRPV4/ mice. Thus we examined the contribution of both maxi-K+ and amiloride-sensitive Na+ channels to the net K+ and Na+ transports in mouse CCDs in the following experiments. As shown in Fig. 5A, a luminal application of 1 µM CTX reduced both K+ secretion and Na+ reabsorption in TRPV4+/+ CCDs at a faster luminal flow rate. Similarly, both K+ secretion and Na+ reabsorption were reduced by the application of 10 µM amiloride to the tubular lumen at a faster luminal flow rate (Fig. 5B). The reduced levels of both K+ secretion and Na+ reabsorption were similar to the levels of the flow-independent components of these ion transports (Fig. 1). The major flow-dependent transport pathways of K+ and Na+ in the luminal membrane of CCDs, therefore, are the maxi-K+ channel and the amiloride-sensitive Na+ channel, respectively. The TRPV4 channel itself might make a minor contribution to K+ secretion and Na+ reabsorption as a transport pathway for these ions in mouse CCDs.
|
20% smaller) in TRPV4/ than in TRPV4+/+ mice after the urine flow (1,273 ± 116 µl·min1·kg BW1 in TRPV4+/+ mice, n = 8, vs. 1,242 ± 101 µl·min1·kg BW1 in TRPV4/ mice, n = 9) was accelerated by an application of furosemide. Similar results were observed in both types of mice receiving a pretreatment with DOCA (Fig. 6B).
|
| DISCUSSION |
|---|
|
|
|---|
The present consequences suggested that the TRPV4 channel in the luminal membrane sensed the flow rate of tubular fluid. The basolateral 4
PDD caused a very small, but statistically significant, increase in K+ secretion and no significant change in Na+ reabsorption. Thus the luminal TRPV4 channel is at least functionally active, although the cytoplasmic localization of the TRPV4 channel just underneath the luminal membrane, e.g., in the endoplasmic reticulum, cannot be ruled out. On the other hand, an increase in the luminal flow or the perfusion pressure might induce mechanical stress by morphological change and may primarily stimulate basolateral TRPV4, which stimulates K+ excretion into the lumen. The additional effect of basolateral 4
PDD on K+ excretion was small, while the additional effect of luminal 4
PDD on K+ excretion was still vivid at a high luminal flow rate. Thus the high flow rate may primarily stimulate the basolateral TRPV4 toward the maximum activation and then activate luminal TRPV4. The strict primary site for TRPV4 to sense the flow rate was thereby obscured and remained unsolved.
Contribution of the TRPV4 channel to flow-dependent K+ secretion in CCDs. The flow-dependent increase in K+ secretion that we observed was accompanied by an increase in Na+ reabsorption in CCDs, which might be explained by the assumption that the nonselective TRPV4 channel worked as a dominant pathway for the flow-dependent transports of K+ and Na+ ions. This alternative explanation, however, could be ruled out because a luminal application of either CTX or amiloride inhibited the flow-dependent increments of both K+ and Na+ transports. The inhibition of the maxi-K+ channel by CTX suppressed the flow-dependent component of K+ secretion and should depolarize the luminal membrane to reduce the driving force of Na+ reabsorption. The inhibition of Na+ channels by amiloride suppressed Na+ reabsorption and should hyperpolarize the luminal membrane to reduce the driving force of K+ secretion. In contrast to our observation, neither iberiotoxin (28) nor CTX (27) reduced the Na+ reabsorption in rabbit CCDs. Although the reason for this discrepancy is unclear, the expression of the Kir1.1 channel might be more abundant in rabbit CCDs than in mouse CCDs. The inhibition of the maxi-K+ channel might depolarize the luminal membrane of rabbit CCDs less than that of mouse CCDs. In either case, it is possible that the activation of the TRPV4 channel in response to an increase in the luminal flow stimulated the maxi-K+ channel to increase K+ secretion, which increases the driving force of Na+ reabsorption because of the hyperpolarization of the luminal membrane.
There was no significant difference between urinary K+ excretions in TRPV4+/+ and TRPV4/ mice in the control period in Fig. 6. On the basis of the single nephron glomerular filtration rate (
8 nl/min) in mice (15), the luminal flow rate in mouse CCDs could be estimated as 1 nl/min or less under normal conditions. Because the urine flow rate in the control period in Fig. 6 was similar to that obtained from the daily urine volume, the luminal flow rate in CCDs should be 1 nl/min or less in this period. Thus the flow-dependent component of K+ secretion in CCDs should be minimal. On the other hand, urinary K+ excretion was significantly smaller (20% smaller) in TRPV4/ than in TRPV4+/+ mice when an application of furosemide accelerated the urine flow rate 2030 times. These results agreed well with those obtained from in vitro microperfusion experiments in both TRPV4+/+ CCDs and TRPV4/ CCDs.
Sensing mechanism of the luminal flow in the K+ secretion. As discussed above, the TRPV4 channel plays an essential role in flow-dependent K+ secretion to stimulate the maxi-K+ channel. The luminal Ca2+ influx via the TRPV4 channel activated by an increase in the luminal flow seems to elicit a series of cellular reactions in CCDs. Namely, elevated [Ca2+]i activates the maxi-K+ channel to increase K+ secretion, resulting in the hyperpolarization of the luminal membrane to increase the driving force of Na+ reabsorption in the CCDs.
On the other hand, the luminal maxi-K+ channel showed Ca2+-independent stretch activation in intercalated cells (IC cells) of rabbit CCDs (13). If flow-dependent K+ secretion is mediated by the Ca2+-independent stretch activation of the maxi-K+ channel, the K+ ions should be flow dependently secreted in mouse CCDs in the presence or absence of the TRPV4 channel. However, we demonstrated in the present study that the flow-dependent component of K+ secretion completely disappeared in the TRPV4/ CCDs. Thus it is likely that the change in the luminal flow is sensed by the TRPV4 channel but not by the maxi-K+ channel.
It was reported that an increase in the luminal flow elevated [Ca2+]i in both principal (PC) and IC cells in rabbit CCDs toward the level of 0.30.4 µM, although the source of Ca2+ was equivocal (28). The elevated level of [Ca2+]i was insufficient to activate the maxi-K+ channel because it was activated by >1 µM Ca2+ at negative membrane voltages (13). On the other hand, it is possible that even a small amount of luminal Ca2+ influx could increase the [Ca2+]i in the local region just underneath the luminal membrane enough to activate the maxi-K+ channel, as proposed in rabbit CNTs (20), even though the average [Ca2+]i was 0.30.4 µM. The expression of the TRPV4 channel can be detected in the luminal membrane of renal tubules (3). Therefore, the flow-sensing mechanism in the CCDs can be explained by assuming that there is luminal expression of the TRPV4 channel. This possibility should be clarified by using isolated membrane patches in the future in TRPV4+/+ and TRPV4/ renal tubules.
Sensitivities of K+ secretion to temperature, mechanical stress, and phorbol ester.
The TRPV4 channel was activated by an increase of the temperature of >28°C (6). In our experiments, which were performed at room temperature, the TRPV4 channel was not fully activated because both K+ secretion and Na+ reabsorption in TRPV4+/+ CCDs were poorly stimulated by 4
PDD at a low flow rate. They were stimulated more strongly at a high flow rate.
Thus preactivation of the TRPV4 channel by luminal flow-induced shear stress underlies the 4
PDD-induced stimulation of the TRPV4 channel in mouse CCDs. This observation suggests that physical stimuli, such as shear stress and heat, are more fundamental activators of the TRPV4 channel in the renal tubules than chemical stimuli. This idea may be supported by a similar observation that PTH stimulated the luminal Ca2+ influx in rabbit CNTs perfused in vitro at higher pressure (1.2 kPa) but not in those perfused at lower pressure (0.2 kPa) (21). In fact, stretch-activated cation channels found in the luminal membrane of rabbit CNTs were not stimulated by the membrane-permeable analog of cAMP, a second messenger of PTH, but the cation channels preactivated by the membrane stretch were highly stimulated by the cAMP analog in cell-attached patch-clamp experiments (21).
In addition to shear stress, viscosity is also thought to play a role in the stimulation of the TRPV4 channel in the flow-dependent mechanism (1). Because luminal fluid in the distal nephron does not contain viscous materials under normal conditions, we did not test the effect of viscosity. However, viscosity is increased in the nephrotic syndrome, and the TRPV4 channel may play a role in K+ loss in that disease.
We conclude that the TRPV4 channel in the luminal or the basolateral membrane plays a cardinal role in sensing the luminal flow in CCDs of the kidney. The activation of the TRPV4 channel allows Ca2+ influx, which results in the activation of the maxi-K+ channel and leads to the secretion of K+ into the luminal fluid. This mechanism is important in the excretion of the total amount of K+ in vivo (4, 9, 16).
| NOTE ADDED IN PROOF |
|---|
|
|
|---|
PDD to either side, because the change in VT by the activation of TRPV4 requires a longer period (FASEB J 20: 18021812, 2006) than the time for the experiment with this perfusion. Therefore, our results support that TRPV4 plays a role in transepithelial permeability suggested in mammary monolayers and may be compatible with the hypothesis that TRPV4 contributes to the Cl shunt in Gordons syndrome (Am J Physiol Renal Physiol 290: F1303F1304, 2006). | GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
1 subunit: immunolocalization in the mammalian connecting tubule and its role in the kaliuretic response to volume expansion. Am J Physiol Renal Physiol 288: F846F854, 2005.This article has been cited by other articles:
![]() |
M. Kottgen, B. Buchholz, M. A. Garcia-Gonzalez, F. Kotsis, X. Fu, M. Doerken, C. Boehlke, D. Steffl, R. Tauber, T. Wegierski, et al. TRPP2 and TRPV4 form a polymodal sensory channel complex J. Cell Biol., August 11, 2008; 182(3): 437 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pech, W. Zheng, T. D. Pham, J. W. Verlander, and S. M. Wall Angiotensin II Activates H+-ATPase in Type A Intercalated Cells J. Am. Soc. Nephrol., January 1, 2008; 19(1): 84 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, X. Gao, R. C. Brown, S. Heller, and R. G. O'Neil Dual role of the TRPV4 channel as a sensor of flow and osmolality in renal epithelial cells Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1699 - F1713. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |